We provide a potential mechanistic pathway by which senescence can lead to steatosis, through inhibition of CDK1 activity, eventually leading to FFA-induced chronic hyperinsulinemia and the consequent insulin resistance. The gene discussed is CDK1; the disease is hyperinsulinism.